Wave Life Sciences WVE Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$183.59M+10.2% | -$204.38M— | —— | —— | —— | ||
| $3.41M-1.0% | $3.44M-1.8% | $3.5M-2.6% | $3.6M-3.6% | $3.73M-4.3% | ||
| $29.08M+16.5% | $24.97M+19.7% | $20.87M+16.4% | $17.92M+17.8% | $15.21M+15.8% | ||
| $0+100% | -$146K— | —— | —— | —— | ||
| —— | —— | —— | —— | $2.44M-28.8% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | -$552K-129% | $1.91M+11.3% | $1.71M-46.9% | ||
| —— | —— | —— | -$98.58M-0.7% | -$97.9M+3.3% | ||
| —— | —— | -$3.92M+28.1% | -$5.45M-77.0% | -$3.08M-736% | ||
| -$184.01M+1.9% | -$187.49M+5.0% | -$197.37M+0.9% | -$199.18M-10.3% | -$180.63M-19.6% | ||
| $992K+38.0% | $719K-10.7% | $805K-14.4% | $940K+37.0% | $686K-26.9% | ||
| -$992K-38.0% | -$719K+10.7% | -$805K+14.4% | -$940K-37.0% | -$686K+26.9% | ||
| $14.35M-3.5% | $14.87M— | —— | —— | —— | ||
| $486.61M-0.3% | $488.24M+485% | $83.52M-67.2% | $254.58M+4.5% | $243.54M-4.1% | ||
| —— | —— | —— | —— | —— | ||
| $301.56M+0.5% | $300.04M+384% | -$105.82M-267% | $63.43M-10.7% | $71.07M-35.8% | ||
| $29.08M+16.5% | $24.97M+19.7% | $20.87M+16.4% | $17.92M+17.8% | $15.21M+15.8% | ||
| $5.59M+3.2% | $5.41M+3.2% | $5.24M+3.2% | $5.08M+3.2% | $4.92M+3.2% | ||
| $3.41M-1.0% | $3.44M-1.8% | $3.5M-2.6% | $3.6M-3.6% | $3.73M-4.3% | ||
| —— | —— | —— | —— | —— | ||
| -$7.88M-3.2% | -$7.64M-3.2% | -$7.4M-3.3% | -$7.16M-3.3% | -$6.94M-3.3% | ||
| —— | —— | -$552K-129% | $1.91M+11.3% | $1.71M-46.9% | ||
| —— | —— | -$3.92M+28.1% | -$5.45M-77.0% | -$3.08M-736% | ||
| $93.37M-1.3% | $94.64M+98.6% | $47.66M+48.0% | $32.19M— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | -$98.58M-0.7% | -$97.9M+3.3% | ||
| -$185M+1.7% | -$188.21M+5.0% | -$198.17M+1.0% | -$200.12M-10.4% | -$181.32M-19.3% | ||
| -$185M+1.7% | -$188.21M+5.0% | -$198.17M+1.0% | -$200.12M-10.4% | -$181.32M-19.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Wave Life Sciences generate?
- Wave Life Sciences (WVE) generated -$184.0M in operating cash flow over the trailing twelve months.
- What is Wave Life Sciences's free cash flow?
- After $992.0K of capital expenditures, Wave Life Sciences's free cash flow was -$185.0M over the trailing twelve months, down 2.0% year over year.
- Where does Wave Life Sciences's cash flow data come from?
- Every line is extracted from Wave Life Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
